Evidence map›Paper›PMID 42529884›Full record

ArticleJournal of Zhejiang University. Science. B2026

Dual-functional nanoplatform for simultaneous degradation of circRNA

Yan Huang, Jialin Ye, Lan Xu, Xingjie Hu, Nan Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan HuangCollege of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Shanghai Engineering Research Center of Green Energy Chemical Engineering, and Shanghai Frontiers Science Center of Biomimetic Catalysis, Shanghai Normal University, Shanghai 200234, China.
Jialin YeCollege of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Shanghai Engineering Research Center of Green Energy Chemical Engineering, and Shanghai Frontiers Science Center of Biomimetic Catalysis, Shanghai Normal University, Shanghai 200234, China.
Lan XuCollege of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Shanghai Engineering Research Center of Green Energy Chemical Engineering, and Shanghai Frontiers Science Center of Biomimetic Catalysis, Shanghai Normal University, Shanghai 200234, China.
Xingjie HuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 201318, China. nchen@shnu.edu.cn, huxingjie@shsmu.edu.cn.
Nan ChenCollege of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Shanghai Engineering Research Center of Green Energy Chemical Engineering, and Shanghai Frontiers Science Center of Biomimetic Catalysis, Shanghai Normal University, Shanghai 200234, China. nchen@shnu.edu.cn.

Funding

the National Natural Science Foundation of China 21974089the Natural Science Foundation of Shanghai 24ZR1455600
6 · The paper itself

Abstract

Circular RNAs (circRNAs) are key post-transcriptional regulators with critical roles in pathogenesis, yet existing tools for their precise manipulation and functional analysis in living cells remain to be developed. A compelling therapeutic target in this field is the circRNA cerebellar degeneration-related protein 1 antisense (

Indexed as

MicroRNAsRNARNA, CircularDNA, CatalyticHumansImidazolesMetal-Organic FrameworksNanoparticlesRNA, Competitive EndogenousRNA, Long NoncodingZeolitesDNA, CatalyticImidazoleslong non-coding RNA CDR1AS, humanMetal-Organic FrameworksMicroRNAsMIRN7-1 microRNA, humanRNARNA, CircularRNA, Competitive EndogenousRNA, Long NoncodingZeolitesZIF-8 metal-organic frameworkCircular RNA (circRNA)DNAzymeGene regulationMicroRNA-7 (miR-7)Zeolitic imidazolate framework-8 (ZIF-8)

Identifiers

PMID42529884
PMCPMC13420507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.